Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in Relapsed Penile Cancer
NCT03114254Phase 2Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Dec 2014
- Primary completion
- Nov 2016
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel in penile cancer, sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Started Dec 2014; status: completed.
02
Drugs
cabazitaxel
03
Conditions
penile cancer
Beyond the preview
Go deeper on NCT03114254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03114254.